CELL AND GENE THERAPY CHALLENGES
Products and services for complex cell and gene therapy environments
Throughout the cell and gene therapy development cycle, there are common challenges that arise. The right partner can help clear the path for your breakthrough cell and gene therapies.
Rigor and reproducibility are essential as therapies advance toward approval.
Inadequately defined protocols for emerging and existing therapies can lead to roadblocks.
Cold Chain logistics and storage challenges complicate clinical trials and manufacturing.
GLOBAL STORAGE LOCATIONS & LOGISTICS NETWORK
From cell banks to cGMP materials and finished products, our trained staff and certified facilities specialize in cold chain storage and management and provide a fully documented audit trail.
AUTOMATED STORAGE SOLUTIONS
Solutions and expertise including cryogenic, supporting detailed inventory tracking, and reporting capabilities.
PROPRIETARY GENOMICS PROTOCOLS
Customers rely on our proprietary hairpin and GC-rich protocols to synthesize and sequence long and difficult DNA sequences with trusted results.
We will guide you through common challenges of advanced therapy development.
How the Whitehead family continues the fight against childhood cancers
In 2010, Emily Whitehead was diagnosed with lymphoblastic leukemia. Just five-years old, she received chemotherapy - the best available treatment at the time. When her cancer returned in 2011, Emily became the first child in the world to receive an experimental CAR T-cell therapy.
STAY IN TOUCH
Be among the first to learn what's newly possible
Want to validate, optimize, or scale up right now? Need to know what's next? Connect with Azenta Life Sciences, leading the way in CGT infrastructure and expertise.